EUVIMEDEUVIMED entdecken
Crossref

Predictors of Early Mortality in Acute Myeloid Leukemia: A Population Based Analysis Using SEER Data

Shahzaib Maqbool, Mohammad Ebad Ur Rehman, Ahmad Iftikhar, Abdur Rehman, Mouzma Ali, Abat Khan, Imran Khan, Muhammad Ibrahim, Faiz Anwer

Clinical Lymphoma Myeloma and Leukemia · 2026-06 · 26 (6) · 377-387

DOI: 10.1016/j.clml.2026.04.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-06. Verfasst von Shahzaib Maqbool und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, HCA Healthcare Kansas City/Centerpoint Medical Center, Independence, MO. Electronic address: shahzaib.maqbool@hcamid…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Acute myeloid leukemia (AML) is associated with high early mortality, especially among older adults and those with limited access to care. This study utilizes a national cancer registry to identify demographic and disease-related predictors of early death in AML patients. METHODS: A retrospective cohort analysis was conducted using data from the Surveillance, Epidemiology, and End Results 8 database (November 2024 submission) covering cases diagnosed between 1975 and 2022. Patients with a diagnosis of non-M3 AML, defined by ICD-O-3 histology codes were included. Two primary endpoints were evaluated: early mortality within one month of diagnosis (EM1) and within 2 months of diagnosis (EM2). Binary logistic regression was performed to identify predictors of early mortality, and odds ratios (ORs) with 95% confidence intervals (CIs) were reported. RESULTS: A total of 37,835 patients with non-M3 AML were included (median age 70 years), with early mortality rates of 33.4% at 1 month (EM1) and 39.7% at 2 months (EM2). Early mortality increased markedly with age, reaching 52.8% (EM1) and 62.3% (EM2) in patients > 75 years (P < .001). Receipt of chemotherapy significantly reduced early mortality, with lower EM1 (20.6% vs. 61.2%) and reduced adjusted odds for both EM1 (OR 0.19; 95% CI, 0.18-0.20) and EM2 (OR 0.12; 95% CI, 0.12-0.13) (P < .001). Across diagnostic eras, outcomes improved progressively from the chemotherapy era (1975-2005) to the HMA era (2006-2017) and venetoclax era (2018-2022), with EM1 declining from 37.1% to 30.7% to 29.1% and EM2 from 43.9% to 36.8% to 34.9% (P < .001). Sociodemographic factors were significant in univariate analyses but not after adjustment. CONCLUSION: Early mortality in non-M3 AML remains high and is strongly influenced by age, chemotherapy receipt, and AML subtype. Improving timely treatment access and supportive care for high-risk patients may substantially reduce early deaths.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteHumansFemaleAgedSEER ProgramMaleRetrospective StudiesMiddle AgedAged, 80 and overAdultPrognosis

Stichwörter der Autor:innen

Acute myeloid leukemiaChemotherapyEarly mortalityPrognostic factorsSEER database

Autor:innen und Institutionen

  • Department of Internal Medicine, HCA Healthcare Kansas City/Centerpoint Medical Center, Independence, MO. Electronic address: shahzaib.maqbool@hcamidwest.com.
  • Department of Internal Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
  • Department of Internal Medicine, The University of Arizona, Tucson, AZ.
  • Department of Internal Medicine, Multan Medical and Dental College, Multan, Pakistan.
  • Division of Haematology and Oncology, Memorial Cancer Institute, Hollywood, FL.
  • Department of Internal Medicine, NYC H+H/Woodhull, New York City, NY.

Zitieren

APA

Maqbool, S., Rehman, M. E. U., Iftikhar, A., Rehman, A., Ali, M., Khan, A., Khan, I., Ibrahim, M., & Anwer, F. (2026). Predictors of Early Mortality in Acute Myeloid Leukemia: A Population Based Analysis Using SEER Data. Clinical Lymphoma Myeloma and Leukemia, 26(6), 377-387. https://doi.org/10.1016/j.clml.2026.04.005

Vancouver

Maqbool S, Rehman MEU, Iftikhar A, Rehman A, Ali M, Khan A, et al. Predictors of Early Mortality in Acute Myeloid Leukemia: A Population Based Analysis Using SEER Data. Clinical Lymphoma Myeloma and Leukemia. 2026;26(6):377-387. doi:10.1016/j.clml.2026.04.005

BibTeX
@article{Maqbool2026,
  author = {Maqbool, Shahzaib and Rehman, Mohammad Ebad Ur and Iftikhar, Ahmad and Rehman, Abdur and Ali, Mouzma and Khan, Abat and Khan, Imran and Ibrahim, Muhammad and Anwer, Faiz},
  title = {Predictors of Early Mortality in Acute Myeloid Leukemia: A Population Based Analysis Using SEER Data},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2026},
  volume = {26},
  number = {6},
  pages = {377--387},
  doi = {10.1016/j.clml.2026.04.005}
}
Kostenlos starten →